Free Trial

Hologic (HOLX) Competitors

Hologic logo
$61.20 +0.35 (+0.57%)
As of 11:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HOLX vs. EW, IDXX, RMD, DXCM, STE, PODD, BAX, GMED, MASI, and TFX

Should you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry.

Hologic vs.

Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$5.44B7.48$4.17B$6.979.93
Hologic$4.04B3.40$789.50M$3.1719.31

Edwards Lifesciences presently has a consensus target price of $79.95, suggesting a potential upside of 15.47%. Hologic has a consensus target price of $84.62, suggesting a potential upside of 38.25%. Given Hologic's stronger consensus rating and higher possible upside, analysts plainly believe Hologic is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
1 Sell rating(s)
13 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.40
Hologic
0 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.41

In the previous week, Hologic had 4 more articles in the media than Edwards Lifesciences. MarketBeat recorded 30 mentions for Hologic and 26 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.50 beat Hologic's score of 1.10 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
24 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Very Positive
Hologic
20 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Edwards Lifesciences received 456 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 70.85% of users gave Edwards Lifesciences an outperform vote while only 69.32% of users gave Hologic an outperform vote.

CompanyUnderperformOutperform
Edwards LifesciencesOutperform Votes
1337
70.85%
Underperform Votes
550
29.15%
HologicOutperform Votes
881
69.32%
Underperform Votes
390
30.68%

Edwards Lifesciences has a net margin of 72.93% compared to Hologic's net margin of 18.42%. Hologic's return on equity of 19.72% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences72.93% 19.40% 14.37%
Hologic 18.42%19.72%10.94%

Edwards Lifesciences has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.

Summary

Edwards Lifesciences beats Hologic on 11 of the 19 factors compared between the two stocks.

Remove Ads
Get Hologic News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HOLX vs. The Competition

MetricHologicX IndustryMedical SectorNASDAQ Exchange
Market Cap$13.75B$10.57B$5.17B$7.12B
Dividend YieldN/A2.01%5.00%4.16%
P/E Ratio19.3316.7521.2517.47
Price / Sales3.406.68349.9987.93
Price / Cash11.6911.9038.1534.64
Price / Book2.881.856.153.79
Net Income$789.50M$344.53M$3.20B$247.35M
7 Day Performance-0.91%-13.70%-1.66%-6.48%
1 Month Performance-5.17%-22.14%-4.96%-10.82%
1 Year Performance-21.51%-11.85%2.15%-8.06%

Hologic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOLX
Hologic
4.7752 of 5 stars
$61.21
+0.6%
$84.62
+38.2%
-22.0%$13.75B$4.04B19.336,940Positive News
EW
Edwards Lifesciences
4.5046 of 5 stars
$72.53
+2.3%
$79.95
+10.2%
-25.1%$42.57B$5.44B10.3917,300Positive News
IDXX
IDEXX Laboratories
4.067 of 5 stars
$420.55
+1.1%
$533.75
+26.9%
-24.2%$34.05B$3.90B39.3710,800Analyst Upgrade
Positive News
RMD
ResMed
4.3725 of 5 stars
$224.17
+1.9%
$249.73
+11.4%
+8.5%$32.86B$4.93B26.428,160Insider Trade
Positive News
DXCM
DexCom
4.8657 of 5 stars
$68.43
+1.0%
$99.82
+45.9%
-56.9%$26.67B$4.03B47.727,600Positive News
STE
STERIS
4.3813 of 5 stars
$226.73
+1.7%
$258.75
+14.1%
-0.1%$22.25B$5.40B48.0718,179Positive News
PODD
Insulet
4.296 of 5 stars
$262.25
+1.4%
$292.06
+11.4%
+48.6%$18.34B$2.07B45.122,600Positive News
Gap Down
BAX
Baxter International
4.6425 of 5 stars
$34.40
+1.9%
$38.56
+12.1%
-32.5%$17.57B$10.64B-26.8360,000
GMED
Globus Medical
4.9266 of 5 stars
$73.28
+1.0%
$97.09
+32.5%
+33.1%$10.08B$2.52B97.722,600Positive News
Gap Down
MASI
Masimo
4.1775 of 5 stars
$166.96
+2.1%
$194.80
+16.7%
+1.3%$8.99B$2.09B114.896,200
TFX
Teleflex
4.3568 of 5 stars
$138.36
+0.4%
$182.63
+32.0%
-39.1%$6.40B$3.05B27.4215,500Analyst Revision
Remove Ads

Related Companies and Tools


This page (NASDAQ:HOLX) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners